Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Alnylam Pharmaceut (ALNY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,648,083
  • Shares Outstanding, K 100,520
  • Annual Sales, $ 89,910 K
  • Annual Income, $ -490,870 K
  • 36-Month Beta 2.69
  • Price/Sales 118.80
  • Price/Cash Flow N/A
  • Price/Book 6.07

Price Performance

See More
Period Period Low Period High Performance
1-Month
94.06 +12.62%
on 06/26/18
108.98 -2.80%
on 07/13/18
+0.67 (+0.64%)
since 06/20/18
3-Month
87.35 +21.27%
on 05/04/18
109.41 -3.18%
on 06/18/18
+8.45 (+8.67%)
since 04/20/18
52-Week
70.76 +49.70%
on 09/08/17
153.99 -31.21%
on 03/20/18
+25.42 (+31.57%)
since 07/20/17

Most Recent Stories

More News
Today's Research Reports on Trending Tickers: Alnylam Pharmaceuticals and Endo International

NEW YORK, NY / ACCESSWIRE / July 19, 2018 / U.S. equities closed mostly higher Wednesday, as investors welcomed quarterly earnings and positive signs of a rapidly growing domestic economy. The Dow Jones...

ALNY : 105.93 (-0.31%)
Alnylam Pharmace Set to Possibly Pullback After Yesterday's Rally of 2.24%

Alnylam Pharmace (NASDAQ:ALNY) traded in a range yesterday that spanned from a low of $102.55 to a high of $105.69. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high...

ALNY : 105.93 (-0.31%)
Regulus Stock Plunges on Cash Concerns Despite Restructuring

Regulus Therapeutics (RGLS) announces strategic and restructuring plans to extend cash runway. However, investors remain skeptical.

ALNY : 105.93 (-0.31%)
IONS : 46.50 (+1.44%)
RGLS : 0.28 (-3.45%)
SNY : 42.35 (+1.05%)
Alnylam Announces Publication of APOLLO Phase 3 Clinical Study Results for Investigational RNAi Therapeutic Patisiran in The New England Journal of Medicine

--a^' Majority of Patients Receiving Patisiran Experienced Improvement in Polyneuropathy and Quality of Life Relative to Baseline a^'

ALNY : 105.93 (-0.31%)
Sanofi's Blood Clotting Drug Gets Positive CHMP Opinion

Sanofi's (SNY) Cablivi for treating acquired thrombotic thrombocytopenic purpura nears approval with CHMP recommendation.

ALNY : 105.93 (-0.31%)
RHHBY : 29.4700 (+1.94%)
SNY : 42.35 (+1.05%)
BIIB : 358.71 (+0.17%)
Medicines Company's Inclisiran Studies to Continue Unmodified

The Medicines Company (MDCO) announces that Independent Data Monitoring Committee has recommended that the ongoing phase III studies of its candidate, inclisiran, will continue without modification.

AGLE : 9.20 (-1.18%)
MDCO : 39.80 (-0.70%)
ALNY : 105.93 (-0.31%)
ANIP : 70.49 (-0.10%)
Report: Developing Opportunities within Valvoline, Parker Drilling, Dean Foods, BioPharmX, Hasbro, and Alnylam Pharmaceuticals -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Valvoline Inc. (NYSE:VVV),...

DF : 10.39 (-0.86%)
BPMX : 0.24 (+3.45%)
VVV : 22.38 (+0.22%)
PKD : 0.30 (unch)
ALNY : 105.93 (-0.31%)
HAS : 93.93 (+0.26%)
SmarTrend Watching for Potential Rebound in Shares of Alnylam Pharmace After 1.51% Loss

Alnylam Pharmace (NASDAQ:ALNY) traded in a range yesterday that spanned from a low of $94.06 to a high of $101.39. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of...

ALNY : 105.93 (-0.31%)
Alnylam to Host Fifth Annual "RNAi Roundtable" Webcast Series

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it plans to host its 5th annual series of "RNAi Roundtable" webcasts this...

ALNY : 105.93 (-0.31%)
Sarepta Pharma Pushes Two Biotech ETFs to New Highs

The encouraging early trial results for a gene therapy for Duchenne muscular dystrophy pushed Sarepta Therapeutics and few biotech ETFs to new highs.

BBP : 46.53 (+0.45%)
SLDB : 43.11 (-2.27%)
BBC : 33.78 (-0.88%)
SBIO : 38.97 (+0.31%)
SRPT : 133.31 (-1.64%)
IBB : 118.26 (-0.08%)
VRTX : 177.40 (-1.51%)
ALNY : 105.93 (-0.31%)
XBI : 100.13 (-0.27%)
ALXN : 135.16 (+0.05%)
BIIB : 358.71 (+0.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators are in flux.

See More Share

Trade ALNY with:

Business Summary

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is applying its therapeutic expertise in RNAi to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies,...

See More

Key Turning Points

2nd Resistance Point 108.90
1st Resistance Point 107.42
Last Price 105.93
1st Support Level 105.10
2nd Support Level 104.26

See More

52-Week High 153.99
Fibonacci 61.8% 122.19
Fibonacci 50% 112.37
Last Price 105.93
Fibonacci 38.2% 102.55
52-Week Low 70.76

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar